TMO - Thermo Fisher Scientific Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Total Revenue
24,868,000
24,358,000
20,918,000
18,274,100
16,965,400
Cost of Revenue
13,799,000
12,994,000
10,961,000
9,459,100
8,782,700
Gross Profit
11,069,000
11,364,000
9,957,000
8,815,000
8,182,700
Operating Expenses
Research Development
985,000
967,000
888,000
754,800
692,300
Selling General and Administrative
6,093,000
4,823,000
4,410,000
4,043,800
3,724,100
Total Operating Expenses
7,078,000
7,531,000
6,892,000
6,176,600
5,731,200
Operating Income or Loss
3,991,000
3,833,000
3,065,000
2,638,400
2,451,500
Interest Expense
704,000
667,000
592,000
469,600
414,900
Total Other Income/Expenses Net
532,000
-41,000
-125,000
-193,300
-130,800
Income Before Tax
4,032,000
3,262,000
2,429,000
2,023,900
1,936,400
Income Tax Expense
491,000
324,000
201,000
-1,400
-43,900
Income from Continuing Operations
3,541,000
2,938,000
2,228,000
2,025,300
1,980,300
Net Income
3,541,000
2,938,000
2,225,000
2,021,800
1,975,400
Net Income available to common shareholders
3,541,000
2,938,000
2,225,000
2,021,800
1,975,400
Reported EPS
Basic
-
7.31
5.64
5.12
4.96
Diluted
-
7.24
5.59
5.09
4.92
Weighted average shares outstanding
Basic
-
402,000
395,000
394,800
398,700
Diluted
-
406,000
398,000
397,400
401,900
EBITDA
-
6,196,000
5,054,000
4,251,500
4,039,500